Preferred Label : Lipodystrophy, congenital generalized, type 2;
Symbol : CGL2;
CISMeF acronym : CGL2;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Berardinelli-seip congenital lipodystrophy, type 2; Lipodystrophy, berardinelli-seip congenital, type 2; Seip syndrome; Lipoatrophic diabetes, congenital; Berardinelli syndrome; Lipodystrophy, total, and acromegaloid gigantism; Brunzell syndrome, bscl2-related;
Description : Congenital generalized lipodystrophy (CGL), also known as Berardinelli-Seip syndrome,
is an autosomal recessive disorder characterized by marked paucity of adipose tissue,
extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early onset
of diabetes (Garg, 2004). For a general description and a discussion of genetic heterogeneity
of congenital generalized lipodystrophy, see CGL1 (608594).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutations in the seipin gene (BSCL2, 606158.0001).;
Laboratory abnormalities : Hyperinsulinemia; Hypertriglyceridemia; Decreased serum leptin; Elevated liver enzymes;
Prefixed ID : #269700;
Origin ID : 269700;
UMLS CUI : C1720863;
Broader ORDO disease(s)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT